98%
921
2 minutes
20
The purpose of this article is to improve recognition and treatment of Wernicke-Korsakoff syndrome. It is well known that Korsakoff syndrome is a chronic amnesia resulting from unrecognized or undertreated Wernicke encephalopathy and is caused by thiamine (vitamin B1) deficiency. The clinical presentation of thiamine deficiency includes loss of appetite, dizziness, tachycardia, and urinary bladder retention. These symptoms can be attributed to anticholinergic autonomic dysfunction, as well as confusion or delirium, which is part of the classic triad of Wernicke encephalopathy. Severe concomitant infections including sepsis of unknown origin are common during the Wernicke phase. These infections can be prodromal signs of severe thiamine deficiency, as has been shown in select case descriptions which present infections and lactic acidosis. The clinical symptoms of Wernicke delirium commonly arise within a few days before or during hospitalization and may occur as part of a refeeding syndrome. Wernicke encephalopathy is mostly related to alcohol addiction, but can also occur in other conditions, such as bariatric surgery, hyperemesis gravidarum, and anorexia nervosa. Alcohol related Wernicke encephalopathy may be identified by the presence of a delirium in malnourished alcoholic patients who have trouble walking. The onset of non-alcohol-related Wernicke encephalopathy is often characterized by vomiting, weight loss, and symptoms such as visual complaints due to optic neuropathy in thiamine deficiency. Regarding thiamine therapy, patients with hypomagnesemia may fail to respond to thiamine. This may especially be the case in the context of alcohol withdrawal or in adverse side effects of proton pump inhibitors combined with diuretics. Clinician awareness of the clinical significance of Wernicke delirium, urinary bladder retention, comorbid infections, refeeding syndrome, and hypomagnesemia may contribute to the recognition and treatment of the Wernicke-Korsakoff syndrome.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9693280 | PMC |
http://dx.doi.org/10.3390/jcm11226755 | DOI Listing |
J Neurol
September 2025
Department of Neurology, College of Medicine, Seoul National University, Seoul, Korea.
Introduction To characterize the epidemiology, risk factors, and clinical presentation of Wernicke encephalopathy (WE), and analyze differences between cases with and without excessive alcohol consumption. Methods A systematic search was conducted in PubMed, Scopus, and Web of Science up to April 1st, 2025. The included studies provided data on prevalence, risk factors, clinical and radiological findings, mortality, and prognosis in patients with WE.
View Article and Find Full Text PDFEur J Clin Nutr
September 2025
Centre Régional de Pharmacovigilance, Service de Pharmacologie périnatale, pédiatrique et adulte, Hopital Cochin, Assistance Publique-Hopitaux de Paris (AP-HP), Paris, France.
Although GLP-1 receptors analogues (RAs) benefits-risks profile has been largely documented in diabetes, higher dosages recently approved in obesity still require further assessment. We describe here the case of a 49-year-old female patient treated with semaglutide for obesity, who presented with Wernicke encephalopathy in a context of iterative vomiting and reduced food intake. Eighteen other cases of Wernicke encephalopathy were reported in literature and in the WHO global safety database (VigiBase).
View Article and Find Full Text PDFAcad Emerg Med
August 2025
Department of Emergency Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin, USA.
Background/objectives: A commonly taught principle when treating emergency department (ED) patients with acute alcohol intoxication is to give thiamine before dextrose to avoid precipitating Wernicke's encephalopathy (WE). We sought to evaluate the prevalence of WE among a national sample of veterans who presented to the ED with alcohol intoxication and who then received dextrose before thiamine.
Methods: This is a retrospective, cross-sectional study of patients presenting to all Veterans Affairs (VA) Emergency Departments (ED) over a 10-year period (2010-2019).
BMC Health Serv Res
August 2025
Department of Obstetric Medicine, Guy's and St Thomas' NHS Foundation Trust, Westminster Bridge Road, London, SE1 7EH, England.
Background: Nausea and vomiting of pregnancy (NVP) affects up to 90% of pregnant women but many struggle to access guideline-recommended care. Following a King’s Policy Institute policy laboratory, arranged to explore barriers to care, it was recommended that a scoping review of current national practice was carried out. This study aims to describe NVP services in England, Scotland and Wales and compare management to national guidance.
View Article and Find Full Text PDF